BRIEF BIOSKETCH
Andrey Bayanov, M.D., Ph.D.
SUMMARY OF WORK EXPERIENCE
2012 – present | Principal Consultant in pipeline/portfolio analysis, strategic planning and R&D for bio/pharma companies and venture funds at Health Recode LLC, Spain |
2010-12 | Medical Affairs Manager at R-Pharm Group, Moscow, Russia |
2007-10 | Consultant at GfK Healthcare and Ipsos CEE, Moscow, Russia |
2003-06 | Adviser and Key Expert for EC, WB and USAID’s health technology development projects in Russia and Ukraine at HLSP Consulting Spain, IREX Russia, and WYG International UK |
1996-03 | Registrar in Psychiatry, then Consultant psychiatrist; pioneered the personalized medicine approach at mental health clinics and general hospitals of Novosibirsk, Russia |
EDUCATION
1994-97 | PhD in Pharmacology; Postgraduate Research Fellowship, Tomsk Research Institute of Pharmacology, Russian Academy of Medical Sciences |
1988-94 | MD, Diploma of Pediatrician; Novosibirsk State Medical University (NSMU), Russia (nostrified as Family Medicine Doctor by the Ministry of Education and Science of Spain, 2005) |
PROFESSIONAL TRAINING
2011-22 | Online seminars in Precision Medicine, Genetics and Pharmacogenomics, Roche Institute, Spain |
2013 | eLearning course in Research Commercialization, National Council of Entrepreneurial Tech Transfer, USA |
2013 | eLearning course in Drug Discovery, Development & Commercialization, UCSD, Skaggs School of Pharmacy and Pharmaceutical Sciences, USA |
2013 | eLearning course in Genomics and Biotechnology, University of Maryland, USA |
2013, 2003 | eLearning course, and Internship in Health Technology Assessment, University of Sheffield, UK, and HLSP Consulting/ Europe, Barcelona, Spain |
2003 | CME courses on innovative treatments for tuberculosis, HIV, and mental disorders, UITB and WPA, Barcelona, Spain |
1997-00 | Residency and advanced trainings in Psychiatry and Behavioral Psychology, NSMU and Russian Medical Academy for Postgraduate Education, Moscow |
KEY QUALIFICATIONS
New Product Portfolio Development:
- Independent thought and judgment to evaluate strategically new bio/pharma science technology developments
- In-depth understanding of the drug development phases and master skills in drug lifecycle strategic planning
- Excellent “first filter” capacities for BD incoming opportunities
- Good skills in in/out-licensing transactions for R&D technologies, products, and marketed brands
- Extensive experience in international/national IP information search and evaluation
- Ability to identify prospective partners, build relationships, and communicate across a variety of audiences.
Pharma Market Intelligence & Analysis:
- Expert skills in market intelligence and comprehensive coverage analysis in any TA to identify best investable niches and marketing strategies
- Hands-on experience in conducting qualitative marketing researches
- Expert specialist in translating of unmet medical needs and scientific insights into functional applications
Personalized Medicine & Clinical Project Development:
- Hands-on experience in scientific research with the ability to review and collate data from the scientific sources
- Good knowledge of GCP, EBM, translational research, precision medicine, HTA, and their application in the drug development phases
- Master skills in integrating of pharmacogenetics and functional genomics data into personalized medicine applications
- In-depth understanding of disease biomarkers and therapeutic targets search, analysis and validation strategies
- Expert skills in preclinical and clinical pharmacological expertise (PK/PD, DMPK and ADME analysis, drug efficacy, safety, pharmacoepidemiology)
Other relevant skills:
- Good knowledge of health policies and technology assessment principles across Europe
- Excellent capacities in gathering, compiling and summarizing a complex set of scientific facts
- Good skills to manage multiple projects, work independently, and lead a team of professionals
- Fluent trilingual Internet surfing of biomedicine knowledge bases, phenome/genome repositories and datasets
- Writing analytical reviews, reports and original scientific issues in English, Spanish and Russian languages